![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Division of Immunology (K.K.), Division of Cellular and Molecular Pharmacology (N.E.N., C.O., L.M.F.L-L., B.O.), Department for Experimental Medical Science, Lund University, Lund, Sweden; Division of Obstetrics and Gynecology, Department of Clinical Science, Lund University, Lund, Sweden (S.H.); HeptaHelix AB (J.B., Å.B., C.O.), Malmö, Sweden; and Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden (R.S., Å.N.)
Here, the ligand binding, activation, and tissue distribution of the orphan G protein-coupled receptor (GPCR) GPR92 were studied. GPR92 binds and is activated by compounds based on the lysophosphatidic acid (LPA) backbone. The binding of LPA to GPR92 was of high affinity (KD = 6.4 ± 0.9 nM) and led to an increase in both phosphoinositide hydrolysis and cAMP production. GPR92 is atypical in that it has a low sequence homology with the classic LPA1-3 receptors (21-22%). Expression of GPR92 is mainly found in heart, placenta, spleen, brain, lung, and gut. Notably, GPR92 is highly expressed in the lymphocyte compartment of the gastrointestinal tract. It is the most abundant GPCR activated by LPA found in the small intestinal intraepithelial CD8+ cytotoxic T cells.
Address correspondence to: Dr. Björn Olde, BMC A12, 22184 Lund, Sweden. E-mail: bjorn.olde{at}med.lu.se
This article has been cited by other articles:
|
|
 |
|
  X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum. Reprod. Update, June 25, 2008; (2008) dmn023v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Valentine, J. I. Fells, D. H. Perygin, S. Mujahid, K. Yokoyama, Y. Fujiwara, R. Tsukahara, J. R. Van Brocklyn, A. L. Parrill, and G. Tigyi Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors J. Biol. Chem., May 2, 2008; 283(18): 12175 - 12187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dottori, J. Leung, A. M. Turnley, and A. Pebay Lysophosphatidic Acid Inhibits Neuronal Differentiation of Neural Stem/Progenitor Cells Derived from Human Embryonic Stem Cells Stem Cells, May 1, 2008; 26(5): 1146 - 1154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Choi, M. Lee, A. L. Shiu, S. J. Yo, G. Hallden, and G. W. Aponte GPR93 activation by protein hydrolysate induces CCK transcription and secretion in STC-1 cells Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1366 - G1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-W. Lee, R. Rivera, A. E. Dubin, and J. Chun LPA4/GPR23 Is a Lysophosphatidic Acid (LPA) Receptor Utilizing Gs-, Gq/Gi-mediated Calcium Signaling and G12/13-mediated Rho Activation J. Biol. Chem., February 16, 2007; 282(7): 4310 - 4317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Choi, M. Lee, A. L. Shiu, S. J. Yo, and G. W. Aponte Identification of a protein hydrolysate responsive G protein-coupled receptor in enterocytes Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G98 - G112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Murph, T. Tanaka, S. Liu, and G. B. Mills Of Spiders and Crabs: The Emergence of Lysophospholipids and Their Metabolic Pathways as Targets for Therapy in Cancer. Clin. Cancer Res., November 15, 2006; 12(22): 6598 - 6602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tanaka, S. Okudaira, Y. Kishi, R. Ohkawa, S. Iseki, M. Ota, S. Noji, Y. Yatomi, J. Aoki, and H. Arai Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid J. Biol. Chem., September 1, 2006; 281(35): 25822 - 25830. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
